# Istituto Oncologico Veneto IRCCS

Source: https://onco.cc/institutions/iov-veneto/  
OnCo record `iov-veneto` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The Veneto region's OECI-accredited comprehensive cancer centre in Padua, strong in breast cancer trials, melanoma and tumour immunology.

## Summary

Founded in 2005, the Istituto Oncologico Veneto is the IRCCS cancer institute of the Veneto region and coordinates the regional oncology network; it is accredited by the OECI as a comprehensive cancer centre. Pierfranco Conte and Valentina Guarneri's breast oncology group led the ShortHER trial of trastuzumab duration and many neoadjuvant studies, the melanoma unit is a leading Italian immunotherapy trial site, and Vincenzo Bronte's immunology programme is known for myeloid-derived suppressor cells. The institute runs gastrointestinal, thoracic and gynaecological oncology, radiotherapy and nuclear medicine across Padua and Castelfranco Veneto, with a phase 1 unit and the University of Padua's oncology school.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: IOV; Veneto Institute of Oncology
- City: Padua, IT
- Type: cancer-center
- Website: https://www.ioveneto.it

## Sources

- Homepage: https://www.ioveneto.it
- Research: https://www.ioveneto.it/ricerca/

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Melanoma](https://onco.cc/cancers/melanoma/)
- fronts: [Immunotherapy](https://onco.cc/fronts/immunotherapy/), [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- technologies: [CDK4/6 inhibitors](https://onco.cc/technologies/cdk46-inhibitor/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/)
- drugs: [Trastuzumab](https://onco.cc/drugs/trastuzumab/)
- institutions: [IEO (European Institute of Oncology)](https://onco.cc/institutions/ieo-milan/), [Organisation of European Cancer Institutes](https://onco.cc/institutions/oeci/)
- people: [Antonio Rosato](https://onco.cc/people/antonio-rosato/), [Patrizia Simionato](https://onco.cc/people/patrizia-simionato/)

---
JSON: https://onco.cc/api/v1/entities/iov-veneto.json